Related Experiment Video
Updated: Dec 28, 2025
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
304
Precision medicine in inflammatory bowel disease: concept, progress and challenges
Simon P Borg-Bartolo1, Ray Kiran Boyapati2,3, Jack Satsangi4
1Department of Gastroenterology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M23 9LT, UK.
F1000Research
|February 13, 2020
Summary
Precision medicine aims to personalize inflammatory bowel disease (IBD) therapies by integrating multi-omic data. This proactive approach predicts susceptibility, tailors treatments, and monitors response for better patient outcomes.
Area of Science:
- Gastroenterology and Immunology
- Genomics and Multi-omics
- Translational Medicine
Background:
- Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are complex, chronic conditions with unclear etiology.
- Current therapeutic strategies for IBD face challenges such as high costs, variable patient response, and loss of efficacy over time.
Purpose of the Study:
- To review progress in precision medicine for IBD, focusing on predicting disease risk and course.
- To explore the personalization of IBD therapies based on individual disease biology.
- To discuss the monitoring of treatment response in the context of precision medicine.
Main Methods:
- Review of current literature on precision medicine applications in IBD.
- Analysis of multi-omic data (genome, exposome, microbiome, immunome) in IBD pathogenesis.
- Synthesis of evidence regarding personalized therapeutic strategies and response monitoring.
Main Results:
- Significant advancements have been made in understanding IBD pathogenesis through multi-omic approaches.
- Precision medicine offers potential for predicting disease susceptibility and tailoring treatments to individual patients.
- Methods for monitoring therapy response are evolving to support personalized care.
Conclusions:
- Precision medicine holds promise for transforming IBD management from reactive to proactive care.
- Integrating diverse data sources is crucial for accurate clinical decision-making in IBD.
- Overcoming challenges in data integration and implementation is necessary to fully realize the benefits of precision medicine in IBD.
Keywords:
Crohn's diseasebiomarkersgenomicsinflammatory bowel diseasemicrobiomeprecision medicineprognosistherapeuticsulcerative colitisMore Related Videos
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
387
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
387
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
565
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565
01:21Inflammatory Bowel Disease V: Surgical Management
375
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
375
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
780
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
780
01:30Inflammatory Bowel Disease II: Crohn's Disease
850
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
850
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
392
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
392